A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)
Girouard, N., Johnson, L., Luecke, E., Demkovich, Z., Jester, T., Li, A., Johnson, P., & van der Straten, A. (2018). A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP). AIDS Research and Human Retroviruses, 34, 107.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article
Epigenetic biomarkers for smoking cessation
Article
A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood
Article